Teva Pharmaceutical on Monday announced the launch of a generic version of Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the United States.
Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths.
Sandoz announced the launch of valsartan tablets, an authorized generic version of Diovan tablets which is used for the treatment of high blood pressure.
Ohm Labs, a wholly owned subsidiary of Ranbaxy Labs, on Friday announced that it received approval from the Food and Drug Administration to manufacture and market valsartan tablets in 40 mg, 80 mg, 160 mg and 320 mg dosage strengths.
The Food and Drug Administration has given tentative approval to a generic drug for treating hypertension, according to agency records.
A court has ruled in favor of Indian generic drug maker Ranbaxy Labs in a case concerning a generic blood pressure drug, the legal firm representing the drug maker said.
A federal judge in Washington has dismissed a suit against the FDA brought up by Mylan for withholding approval for the company to sell a generic version of Novartis AG’s heart pill, Diovan.
Generic drug maker Sandoz has launched an authorized generic version of a drug used to treat hypertension.
The Food and Drug Administration has approved a blood pressure medication made by Mylan.
A class of drugs commonly used to control blood pressure does not increase patients’ risk of developing cancer, according to the Food and Drug Administration.
A blood pressure drug made by Swiss drug maker Novartis has won an award from the Healthcare Compliance Packaging Council.
The market for hypertension drugs will drop by $3 billion by the end of the...
Daniel Vasella will step down as CEO of Novartis to focus on his position as...